Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001808343-25-000004
Filing Date
2025-12-23
Accepted
2025-12-23 16:41:35
Documents
1
Period of Report
2025-12-22

Document Format Files

Seq Description Document Type Size
1 form4-12232025_091227.html 4  
1 form4-12232025_091227.xml 4 8437
  Complete submission text file 0001808343-25-000004.txt   9845
Mailing Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011
Business Address 18702 N. CREEK PARKWAY SUITE 100 BOTHELL WA 98011 610-321-3700
Immunome Inc. (Issuer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1601 BRYAN STREET, SUITE 4141 DALLAS TX 75201
Business Address
Barchas Isaac (Reporting) CIK: 0001808343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39580 | Film No.: 251601269